| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.990 | 9.820 | 13.203 | 15.789 | 14.811 | 20.971 | 21.809 | 22.327 | 23.065 |
| Total Income - EUR | - | 5.990 | 9.820 | 13.203 | 15.789 | 14.811 | 20.971 | 21.809 | 29.807 | 23.071 |
| Total Expenses - EUR | - | 1.375 | 4.967 | 7.107 | 6.726 | 6.194 | 7.758 | 9.926 | 22.370 | 18.266 |
| Gross Profit/Loss - EUR | - | 4.615 | 4.854 | 6.096 | 9.062 | 8.617 | 13.213 | 11.883 | 7.437 | 4.806 |
| Net Profit/Loss - EUR | - | 4.435 | 4.559 | 5.700 | 8.589 | 8.195 | 12.659 | 11.327 | 5.747 | 3.500 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Caliani Nicomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 10.711 | 14.508 | 7.867 | 4.010 | 2.016 | 29.048 | 19.934 |
| Current Assets | - | 4.546 | 8.937 | 3.815 | 3.437 | 5.406 | 16.046 | 10.213 | 1.547 | 190 |
| Inventories | - | 0 | 0 | 0 | 323 | 0 | 0 | 0 | 848 | 88 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 4.546 | 8.937 | 3.815 | 3.113 | 5.406 | 16.046 | 10.213 | 698 | 102 |
| Shareholders Funds | - | 4.479 | 8.858 | 14.395 | 17.542 | 12.909 | 19.702 | 11.502 | 17.215 | 16.598 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 67 | 79 | 131 | 403 | 363 | 354 | 726 | 13.636 | 3.796 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Caliani Nicomed Srl